Quantcast

Latest Tyrosine kinase inhibitors Stories

2015-01-05 08:29:52

NEW YORK, Jan. 5, 2015 /PRNewswire/ -- Exelixis, Inc. (NASDAQ: EXEL) is a biotechnology company that develops and markets treatments for cancer.

2014-12-25 23:00:21

RnRMarketResearch.com adds “Nintedanib (Colorectal Cancer) – Forecast and Market Analysis to 2023” to its store.

2014-10-29 08:33:36

MTD Confirmed in Combination with Topotecan, First Patient Dosed in Cohort Expansion SAN DIEGO, Oct. 29, 2014 /PRNewswire/ -- MEI Pharma, Inc.

2014-07-17 16:26:09

NEW YORK, July 17, 2014 /PRNewswire/ -- Exelixis, Inc. (Nasdaq: EXEL) is a development stage biotech company.

2014-05-15 08:31:37

ROCKVILLE, Md., May 15, 2014 /PRNewswire/ -- EntreMed, Inc.


Word of the Day
metagrabolized
  • totally perplexed and mixed up.
The word 'metagrabolized' is also spelled 'metagrobolized'.
Related